Abramson Cancer Center at Penn Medicine: Not applicable (device, behavioral) study in Genetic Predisposition to Cancer (1000 participants)
Abramson Cancer Center at Penn Medicine: Not applicable (device, behavioral) study in Genetic Predisposition to Cancer (1000 participants). Its enrollment of 1,000 is top-decile (94th percentile of 8,879 records). Dated 2 days ago, it is inside the fresh trigger window. Score 55/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 1,000 · 94th percentile of 8,879 ClinicalTrialStartPulse records · 12.5x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related US ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Sponsor type | Academic and hospital |
| Study | Breast Cancer Risk Assessment and Management Program |
| NCT ID | NCT07911592 |
| Phase | Not applicable (device, behavioral) |
| Status | enrolling by invitation |
| Conditions | Genetic Predisposition to Cancer |
| Intervention types | other |
| Target enrollment | 1000 |
| Site countries | United States |
| Posted | 2026-11-03 |
| Planned start | 2026-09-23 |
| Event | Newly registered study |
| Event date | 2026-11-03 |
| enrollment percentile | 94th of 8,879 (median 80, 12.5x median) |
| Peer records CSV (500 US records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Abramson Cancer Center at Penn Medicine
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of US records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Abramson Cancer Center at Penn Medicine + 500 US peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-11-03
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (US first): Sanofi · Pfizer · National Institute of Arthritis and Musculoskeletal and Skin · Apple Inc. · National Cancer Institute (NCI) · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Abramson Cancer Center at Penn Medicine and 2,512 US peers
- US ClinicalTrialStartPulse records like this one: 2,512
- Abramson Cancer Center at Penn Medicine's enrollment: 94th percentile of 8,879 records
- Timing: High: dated in the last 7 days
- Estimated pipeline if you contact every US peer: $502,400 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
55 / 100 Score
- Posted in the last two weeks.
- 1000 participants planned.
What is the ClinicalTrialStartPulse record for Abramson Cancer Center at Penn Medicine?
Abramson Cancer Center at Penn Medicine registered a Not applicable (device, behavioral) study (NCT07911592) in Genetic Predisposition to Cancer targeting 1000 participants, posted 2026-11-03.
How does Abramson Cancer Center at Penn Medicine compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 1,000 is 12.5x the median of 80 across 8,879 records. It is fresh: dated 2 days ago, inside the window where early outreach matters most.
Abramson Cancer Center at Penn Medicine vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Abramson Cancer Center at Penn Medicine | US | 1,000 | 94th | 2026-11-03 |
| Inari Medical | US | 1,200 | 95th | 2026-11-03 |
| DePuy International | US | 1,542 | 96th | 2026-11-03 |
| Mentor Worldwide, LLC | US | 400 | 87th | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Not applicable (device, behavioral) ClinicalTrialStartPulse: United States sites ClinicalTrialStartPulse: 1,000+
More US public-record feeds
U.S. DOT Injury/Illness Summary Pulse in US U.S. DOT FRA Regulated Mode Major Security Events Pulse in US U.S. DOT Crossing Inventory Data Pulse in US U.S. DOT Insur - All With History Pulse in US USAC Telecom CAF Locations Obligation and Deployment by Speed Tier Data Pul in US U.S. CDC 2022 Final Assisted Reproductive Technology Summary Pulse in US U.S. DOT Rail Equipment Accident/Incident Data Subset Pulse in US U.S. DOT Monthly Modal Time Series Pulse in US
How to monitor Abramson Cancer Center at Penn Medicine and peer not applicable (device, behavioral) records
Get new ClinicalTrialStartPulse records like Abramson Cancer Center at Penn Medicine by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.